Elan

Analyst upgrades drugmaker Elan on higher expectations for multiple sclerosis drug Tysabri
Yahoo/AP
Thu, 08/25/11 - 08:24 am
Elan
Biogen Idec
MS
Tysabri
multiple sclerosis
Good Biotech Stocks for a Bear Market
TheStreet.com
Tue, 08/9/11 - 01:27 pm
Elan
Targacept
Dendreon
Gilead Sciences
Sequenom
Vertex Pharmaceuticals
Amgen
Alexion
Biogen Idec
Celgene
3 Undervalued Biotechs With Buyout Potential
Seeking Alpha
Wed, 08/3/11 - 11:08 am
Biogen Idec
Abbott Laboratories
Elan
Adeona
Acorda Therapeutics
M&A
Elan Second-Quarter Loss Narrows on Higher Sales of Tysabri
Bloomberg
Wed, 07/27/11 - 02:37 pm
earnings
Elan
Lilly Study Imperils Alzheimer's Drugs
TheStreet.com
Wed, 07/27/11 - 12:32 pm
Eli Lilly
Pfizer
JNJ
Bristol-Myers Squibb
semagacestat
Elan
Alzheimer's disease
Elan's Management Is Creating Value
Motley Fool
Sat, 07/23/11 - 04:41 pm
Elan
Alkermes Sees 2012 Revenue Up to $480 Million on Elan Deal
Bloomberg
Mon, 07/18/11 - 05:35 pm
Elan
Alkermes
earnings
It May Be Time for Amylin and Lilly to Head to Divorce Court
Seeking Alpha
Fri, 05/27/11 - 10:50 am
Eli Lilly
Amylin
restraining order
Alkermes
Bristol-Myers Squibb
Elan
GSK
JNJ
Lexicon Pharmaceuticals
Novo Nordisk
Takeda
Elan move makes it a sitting duck for big boys
Independent, Ireland
Mon, 05/16/11 - 09:30 am
Elan
M&A
Alkermes
JNJ
Alkermes to Buy Elan Drug Technology Unit for $960 Million
Bloomberg
Mon, 05/9/11 - 09:14 am
Elan
M&A
Alkermes
Are You Missing Something Easy at Elan?
Motley Fool
Wed, 04/27/11 - 11:37 am
Elan
Elan turns 1Q profit as Tysabri sales rise
Yahoo/AP
Wed, 04/20/11 - 12:04 pm
Elan
earnings
EU Panel Recommends That Elan Update Tysabri MS Drug Label
Bloomberg
Mon, 04/18/11 - 10:59 am
Europe
Elan
MS
multiple sclerosis
Tysabri
Human Genome Sciences Will Be Profitable, Eventually
Motley Fool
Thu, 04/14/11 - 10:33 pm
Human Genome Sciences
GSK
Benlysta
Bayer
ONYX Pharmaceuticals
Elan
Biogen Idec
Celgene Settles with Elan
Yahoo/Zacks
Sat, 04/9/11 - 11:03 am
Celgene
Elan
Biotech: Top 3 Analyst Picks
Seeking Alpha
Thu, 04/7/11 - 01:39 pm
Elan
Protalix BioTherapeutics
InterMune
Elan Up the Most in 3 Months After Positive Tysabri Comments
Bloomberg
Wed, 04/6/11 - 07:36 pm
Elan
Tysabri
bapineuzumab
Making sense of the Alzheimer's drug pipeline
Fierce Biotech Research
Tue, 03/15/11 - 12:31 pm
Alzheimer's disease
Razadyne
Nivalin
Ortho-McNeil-Janssen
Exelon
Novartis
Aricept
Eisai
Pfizer
Namenda
Merz
Forest Labs
Eli Lilly
Elan
JNJ
Roche
MorphoSys
Elan Announces First European Commission Approval Of Injectable Treatment Using Elan's NanoCrystal(R) Technology
Medical News Today
Sun, 03/13/11 - 11:39 am
Elan
Nanocrystal
schizophrenia
Xeplion
Elan Pharmaceuticals pleads guilty in Zonegran case
Bizjournals.com
Tue, 03/1/11 - 09:15 am
Elan
Zonegran
lawsuits

Pages